DK0738712T3 - Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning - Google Patents

Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning

Info

Publication number
DK0738712T3
DK0738712T3 DK96105873T DK96105873T DK0738712T3 DK 0738712 T3 DK0738712 T3 DK 0738712T3 DK 96105873 T DK96105873 T DK 96105873T DK 96105873 T DK96105873 T DK 96105873T DK 0738712 T3 DK0738712 T3 DK 0738712T3
Authority
DK
Denmark
Prior art keywords
indenoylguanidines
antiarrhythmic
substituted
cardioprotective effect
useful
Prior art date
Application number
DK96105873T
Other languages
Danish (da)
English (en)
Inventor
Nirogi Venkata Sat Ramakrishna
Tulsidas Sitaram More
Anagha Suhas Kulkarni
Roa Venkate Satya Ve Vadlamudi
Anil Vatantrao Ghate
Ravindra Dattatraya Gupte
Bansi Lal
Dr Scholz Wolfgang
Dr Lang Hans-Jochen
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0738712T3 publication Critical patent/DK0738712T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
DK96105873T 1995-04-18 1996-04-15 Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning DK0738712T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95105724 1995-04-18
US08/633,223 US5733934A (en) 1995-04-18 1996-04-16 Antiarrythmic and cardioprotective substituted indenoylguanidines

Publications (1)

Publication Number Publication Date
DK0738712T3 true DK0738712T3 (da) 2000-03-06

Family

ID=26138562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96105873T DK0738712T3 (da) 1995-04-18 1996-04-15 Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning

Country Status (23)

Country Link
US (1) US5733934A (cs)
EP (1) EP0738712B1 (cs)
JP (1) JPH08291131A (cs)
CN (1) CN1061648C (cs)
AT (1) ATE183498T1 (cs)
AU (1) AU706055B2 (cs)
BR (1) BR9601989A (cs)
CA (1) CA2174406A1 (cs)
CZ (1) CZ291538B6 (cs)
DE (1) DE69603771T2 (cs)
DK (1) DK0738712T3 (cs)
ES (1) ES2135811T3 (cs)
GR (1) GR3031540T3 (cs)
HU (1) HUP9600998A3 (cs)
IL (1) IL117927A (cs)
NO (1) NO305655B1 (cs)
NZ (1) NZ286380A (cs)
PL (1) PL182566B1 (cs)
RU (1) RU2182902C2 (cs)
SI (1) SI0738712T1 (cs)
SK (1) SK282011B6 (cs)
TR (1) TR199600316A1 (cs)
ZA (1) ZA963046B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0837055A1 (en) * 1996-07-30 1998-04-22 Hoechst Aktiengesellschaft Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
TW462964B (en) * 1998-05-26 2001-11-11 Sumitomo Pharma Guanidine derivatives for the treatment and prevention of disorders caused by inhibiting hyperactivity of Na/H exchange transport system and process for producing the same
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
EP1180029A4 (en) 1999-04-23 2002-10-02 Bristol Myers Squibb Co BICYCLIC ACYL IHIBITORING SODIUM / PROTON EXCHANGER AND RELATED PROCEDURE.
KR101153254B1 (ko) * 2003-06-26 2012-07-02 바이오트론 리미티드 항바이러스 화합물 및 방법
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556673T3 (da) * 1992-02-15 1998-04-14 Hoechst Ag o-Substituerede benzoylguanidiner til behandling og profylakse af hjerterytmeforstyrrelser og iskæmisk inducerede skader samt til inhiberering af celleproliferation
DE4326005A1 (de) * 1993-08-03 1995-02-09 Hoechst Ag Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4327244A1 (de) * 1993-08-13 1995-02-16 Hoechst Ag Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
DE69603771T2 (de) 2000-09-07
CN1061648C (zh) 2001-02-07
AU5067696A (en) 1996-10-31
HU9600998D0 (en) 1996-06-28
ZA963046B (en) 1996-10-22
SK282011B6 (sk) 2001-10-08
IL117927A0 (en) 1996-08-04
RU2182902C2 (ru) 2002-05-27
ES2135811T3 (es) 1999-11-01
MX9601424A (es) 1997-07-31
SK48396A3 (en) 1996-12-04
CA2174406A1 (en) 1996-10-19
AU706055B2 (en) 1999-06-10
PL182566B1 (pl) 2002-01-31
NO961521L (no) 1996-10-21
IL117927A (en) 2001-12-23
CN1140164A (zh) 1997-01-15
BR9601989A (pt) 1998-04-07
HUP9600998A2 (en) 1997-01-28
GR3031540T3 (en) 2000-01-31
JPH08291131A (ja) 1996-11-05
US5733934A (en) 1998-03-31
NO305655B1 (no) 1999-07-05
NZ286380A (en) 1997-09-22
EP0738712B1 (en) 1999-08-18
ATE183498T1 (de) 1999-09-15
TR199600316A1 (tr) 1997-03-21
CZ109696A3 (en) 1996-11-13
DE69603771D1 (de) 1999-09-23
EP0738712A1 (en) 1996-10-23
CZ291538B6 (cs) 2003-03-12
HUP9600998A3 (en) 1997-11-28
NO961521D0 (no) 1996-04-17
SI0738712T1 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
DE68920125D1 (de) Pyrimidindion-Derivate, Verfahren zu deren Herstellung und diese enthaltende antiarrythmische Mittel.
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
DE69030206D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
EA199901014A1 (ru) C-4"-замещенные макролидные производные
FI954130A0 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
ZA944739B (en) Amide and urea derivatives having anti-hypercholesteremic activity their preparation and their therapeutic uses
DK0738712T3 (da) Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
DE68917772D1 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
DE68903019D1 (de) 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridin-derivate und isomere.
DE69533833D1 (de) Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AR004481A1 (es) Indenoilguanidinas sustituidas antiarritmicas y cardioprotectoras
ATE109454T1 (de) Catecholaminester.
MX9606397A (es) Cromanilsulfonil(tio)ureas sustituidas, procedimientos para prepararlas, y su utilizacion en preparados farmaceuticos, asi como preparados farmaceuticos que las contienen.